Publication: Controllable encapsulation of α-mangostin with quaternized β-cyclodextrin grafted chitosan using high shear mixing
dc.contributor.author | Sarunya Phunpee | en_US |
dc.contributor.author | Kunat Suktham | en_US |
dc.contributor.author | Suvimol Surassmo | en_US |
dc.contributor.author | Suwatchai Jarussophon | en_US |
dc.contributor.author | Chompoonut Rungnim | en_US |
dc.contributor.author | Apinan Soottitantawat | en_US |
dc.contributor.author | Satit Puttipipatkhachorn | en_US |
dc.contributor.author | Uracha Rungsardthong Ruktanonchai | en_US |
dc.contributor.other | Chulalongkorn University | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.contributor.other | Thailand National Science and Technology Development Agency | en_US |
dc.date.accessioned | 2019-08-28T06:53:00Z | |
dc.date.available | 2019-08-28T06:53:00Z | |
dc.date.issued | 2018-03-01 | en_US |
dc.description.abstract | © 2017 Elsevier B.V. In this study, the inclusion complex formation between α-mangostin and water-soluble quaternized β-CD grafted-chitosan (QCD-g-CS) was investigated. Inclusion complex formation with encapsulation efficiency (%EE) of 5, 15 and 75% can be varied using high speed homogenizer. Tuning %EE plays a role on physicochemical and biological properties of α-mangostin/QCD-g-CS complex. Molecular dynamics simulations indicate that α-mangostin is included within the hydrophobic β-CD cavity and being absorbed on the QCD-g-CS surface, with these results being confirmed by Fourier transform infrared (FTIR) spectroscopy. Probing the release characteristics of the inclusion complex at various %EE (5%, 15% and 75%) in simulated saliva (pH 6.8) demonstrated that α-mangostin release rates were dependent on % EE (order 5% > 15% > 75%). Additionally, higher antimicrobial and anti-inflammation activities were observed for the inclusion complex than those of free α-mangostin due to enhance the solubility of α-mangostin through the inclusion complex with QCD-g-CS. | en_US |
dc.identifier.citation | International Journal of Pharmaceutics. Vol.538, No.1-2 (2018), 21-29 | en_US |
dc.identifier.doi | 10.1016/j.ijpharm.2017.12.016 | en_US |
dc.identifier.issn | 18733476 | en_US |
dc.identifier.issn | 03785173 | en_US |
dc.identifier.other | 2-s2.0-85040354898 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/47324 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85040354898&origin=inward | en_US |
dc.subject | Pharmacology, Toxicology and Pharmaceutics | en_US |
dc.title | Controllable encapsulation of α-mangostin with quaternized β-cyclodextrin grafted chitosan using high shear mixing | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85040354898&origin=inward | en_US |